{"id":358028,"date":"2023-05-17T13:05:09","date_gmt":"2023-05-17T11:05:09","guid":{"rendered":"https:\/\/medizinonline.com\/carcinoma-de-mama-con-metastasis-osteoblastica-diseminada\/"},"modified":"2023-05-17T13:07:55","modified_gmt":"2023-05-17T11:07:55","slug":"carcinoma-de-mama-con-metastasis-osteoblastica-diseminada","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/carcinoma-de-mama-con-metastasis-osteoblastica-diseminada\/","title":{"rendered":"Carcinoma de mama con met\u00e1stasis osteobl\u00e1stica diseminada"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>M\u00e1s del 70% de las enfermas de c\u00e1ncer de mama son diagnosticadas como receptor hormonal positivo y HER2 negativo (HR+\/HER2-) [1]. Los datos de los ensayos cl\u00ednicos demuestran que una terapia combinada con inhibidores CDK4\/6 puede aumentar la supervivencia sin progresi\u00f3n (SLP) y la supervivencia global (SG) [2-5]. Lo mismo ocurri\u00f3 en el caso presentado de una paciente de 81 a\u00f1os con carcinoma de mama HR+\/HER2- recurrente.<\/strong><\/p>\n\n<!--more-->\n\n<p class=\"wp-block-paragraph\">Vea en el v\u00eddeo todos los detalles del caso presentado por el PD Dr. med. Marcus Vetter, del Centro de Oncolog\u00eda y Hematolog\u00eda del Hospital Cantonal de Basilea.<\/p>\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n<figure class=\"wp-block-embed is-type-video is-provider-vimeo wp-block-embed-vimeo wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"Vetter_DE_FINAL\" data-src=\"https:\/\/player.vimeo.com\/video\/814171020?h=cd373566bd&amp;dnt=1&amp;app_id=122963\" width=\"1160\" height=\"653\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" allowfullscreen src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe>\n<\/div><\/figure>\n\n<p class=\"wp-block-paragraph\">Referencias<\/p>\n\n<p class=\"wp-block-paragraph\">Blows, F.M., et al, <em>Subtipificaci\u00f3n del c\u00e1ncer de mama mediante inmunohistoqu\u00edmica para investigar la relaci\u00f3n entre el subtipo y la supervivencia a corto y largo plazo: un an\u00e1lisis colaborativo de los datos de 10.159 casos de 12 estudios<\/em>. PLoS Med, 2010. <strong>7<\/strong>(5): p. e1000279.<\/p>\n\n<p class=\"wp-block-paragraph\">2 Goyal, R.K., et al, <em>Supervivencia global asociada a los inhibidores CDK4\/6 en pacientes con c\u00e1ncer de mama metast\u00e1sico HR+\/HER2- en Estados Unidos: Un estudio poblacional SEER-Medicare<\/em>. Cancer, 2023. <strong>129<\/strong>(7): p. 1051-1063.<\/p>\n\n<p class=\"wp-block-paragraph\">Goyal, R.K., et al, <em>Impacto de los inhibidores CDK4\/6 en la utilizaci\u00f3n de la quimioterapia en l\u00edneas terap\u00e9uticas anteriores para el c\u00e1ncer de mama metast\u00e1sico HR+\/HER2- en Estados Unidos.<\/em> Breast Cancer Res Treat, 2023. <strong>198<\/strong>(1): p. 159-166.<\/p>\n\n<p class=\"wp-block-paragraph\">4. Li, J., et al, <em>Cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer: a meta-analysis of randomized clinical trials.<\/em>Breast Cancer Res Treat, 2020. <strong>180<\/strong>(1): p. 21-32.<\/p>\n\n<p class=\"wp-block-paragraph\">Elfgen, C. y V. Bjelic-Radisic, <em>Targeted Therapy in HR+ HER2- Metastatic Breast Cancer: Current Clinical Trials and Their Implications for CDK4\/6 Inhibitor Therapy and beyond Treatment Options.<\/em>Cancers (Basilea), 2021. <strong>13<\/strong>(23).<\/p>\n\n<p class=\"wp-block-paragraph\">Las referencias est\u00e1n disponibles previa solicitud.<\/p>\n\n<p class=\"wp-block-paragraph\">Puede encontrar la informaci\u00f3n t\u00e9cnica actual de Ibrance\u00ae en<a> www.swissmedicinfo.ch.<\/a> <\/p>\n\n<p class=\"wp-block-paragraph\">PP-IBR-CHE-0423 Abr 2023<\/p>\n\n<p class=\"wp-block-paragraph\">Contribuci\u00f3n en l\u00ednea desde el 17.05.2023<\/p>\n","protected":false},"excerpt":{"rendered":"<p>M\u00e1s del 70% de las enfermas de c\u00e1ncer de mama son diagnosticadas como receptor hormonal positivo y HER2 negativo (HR+\/HER2-) [1]. Los datos de los ensayos cl\u00ednicos demuestran que una&hellip;<\/p>\n","protected":false},"author":14,"featured_media":355335,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Caso del paciente ","footnotes":""},"category":[11296,11336,11552],"tags":[],"powerkit_post_featured":[],"class_list":["post-358028","post","type-post","status-publish","format-standard","has-post-thumbnail","category-contenido-para-socios","category-oncologia","category-rx-es","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-01 19:30:56","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/358028","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=358028"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/358028\/revisions"}],"predecessor-version":[{"id":358033,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/358028\/revisions\/358033"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/355335"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=358028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=358028"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=358028"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=358028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}